Unknown

Dataset Information

0

Clinical Characterization of Patients With Autosomal Dominant Short Stature due to Aggrecan Mutations.


ABSTRACT: Context:Heterozygous mutations in the aggrecan gene (ACAN) cause autosomal dominant short stature with accelerated skeletal maturation. Objective:We sought to characterize the phenotypic spectrum and response to growth-promoting therapies. Patients and Methods:One hundred three individuals (57 females, 46 males) from 20 families with autosomal dominant short stature and heterozygous ACAN mutations were identified and confirmed using whole-exome sequencing, targeted next-generation sequencing, and/or Sanger sequencing. Clinical information was collected from the medical records. Results:Identified ACAN variants showed perfect cosegregation with phenotype. Adult individuals had mildly disproportionate short stature [median height, -2.8 standard deviation score (SDS); range, -5.9 to -0.9] and a history of early growth cessation. The condition was frequently associated with early-onset osteoarthritis (12 families) and intervertebral disc disease (9 families). No apparent genotype-phenotype correlation was found between the type of ACAN mutation and the presence of joint complaints. Childhood height was less affected (median height, -2.0 SDS; range, -4.2 to -0.6). Most children with ACAN mutations had advanced bone age (bone age - chronologic age; median, +1.3 years; range, +0.0 to +3.7 years). Nineteen individuals had received growth hormone therapy with some evidence of increased growth velocity. Conclusions:Heterozygous ACAN mutations result in a phenotypic spectrum ranging from mild and proportionate short stature to a mild skeletal dysplasia with disproportionate short stature and brachydactyly. Many affected individuals developed early-onset osteoarthritis and degenerative disc disease, suggesting dysfunction of the articular cartilage and intervertebral disc cartilage. Additional studies are needed to determine the optimal treatment strategy for these patients.

SUBMITTER: Gkourogianni A 

PROVIDER: S-EPMC5413162 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinical Characterization of Patients With Autosomal Dominant Short Stature due to Aggrecan Mutations.

Gkourogianni Alexandra A   Andrew Melissa M   Tyzinski Leah L   Crocker Melissa M   Douglas Jessica J   Dunbar Nancy N   Fairchild Jan J   Funari Mariana F A MF   Heath Karen E KE   Jorge Alexander A L AA   Kurtzman Tracey T   LaFranchi Stephen S   Lalani Seema S   Lebl Jan J   Lin Yuezhen Y   Los Evan E   Newbern Dorothee D   Nowak Catherine C   Olson Micah M   Popovic Jadranka J   Pruhová Štepánka Š   Elblova Lenka L   Quintos Jose Bernardo JB   Segerlund Emma E   Sentchordi Lucia L   Shinawi Marwan M   Stattin Eva-Lena EL   Swartz Jonathan J   Angel Ariadna González Del AG   Cuéllar Sinhué Diaz SD   Hosono Hidekazu H   Sanchez-Lara Pedro A PA   Hwa Vivian V   Baron Jeffrey J   Nilsson Ola O   Dauber Andrew A  

The Journal of clinical endocrinology and metabolism 20170201 2


<h4>Context</h4>Heterozygous mutations in the aggrecan gene (ACAN) cause autosomal dominant short stature with accelerated skeletal maturation.<h4>Objective</h4>We sought to characterize the phenotypic spectrum and response to growth-promoting therapies.<h4>Patients and methods</h4>One hundred three individuals (57 females, 46 males) from 20 families with autosomal dominant short stature and heterozygous ACAN mutations were identified and confirmed using whole-exome sequencing, targeted next-gen  ...[more]

Similar Datasets

| S-EPMC4121031 | biostudies-literature
| S-EPMC5686699 | biostudies-literature
| S-EPMC4501863 | biostudies-literature
| S-EPMC3995570 | biostudies-literature
| S-EPMC5690581 | biostudies-literature
| S-EPMC7719087 | biostudies-literature
| S-EPMC7447401 | biostudies-literature
| S-EPMC5974024 | biostudies-literature
| S-EPMC7442278 | biostudies-literature
| S-EPMC4059519 | biostudies-literature